Between 2019 and 2023, the market grew at a CAGR of 9%, driven by the rising health-consciousness of consumers, particularly millennial and Gen-Z parents. As precision nutrition technologies advance, ...

Covering Saudi Arabia’s markets, the report includes: It encompasses a robust vendor analysis tailored to assist clients in enhancing their market positioning. Specifically, the report furnishes a ...

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

In the chart on the right, the progressive improvements in ... on the SG&A line and to the extent that our partners are able ...

My name is Daniel Amir, VP and head of investor relations. After the closing of the market today, we issued our shareholder ...

Additionally, OrthoPediatrics raised its full-year 2024 revenue guidance, indicating confidence in continued growth. The company is recognized as a differentiated player in the pediatric ...

Third Quarter 2024 Results Key Financial Results Revenue: US$54.6m (up 37% from ...

Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial results ...

On track to report interim data in six-month evaluable patients in ADVANCED-2 trial of TARA-002 in NMIBC in 4Q 2024 Expect to report interim 12-month data in ADVANCED-2 trial of TARA-002 in NMIBC in ...

MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology ...